SCHEMBL7659750

SCHEMBL7659750

N#Cc1ccc(Cn2ccnc2CN2CCN(c3cccc(Cl)c3)C(=O)C2)cc1

nearest known ligand 0.69

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FNTA P49354 20/20 0.69
PGGT1B P53609 16/20 0.69
FNTB P49356 14/20 0.69
NRAS P01111 1/20 0.69
HRAS P01112 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7182161 0.99 FNTA (0.68) FNTAPGGT1BFNTBNRASHRAS
Hydrochloric Acid SCHEMBL5891602 0.99 FNTA (0.68) FNTAPGGT1BFNTBNRASHRAS
SCHEMBL3499312 0.91 FNTA (0.57) FNTAPGGT1BFNTBNRASHRAS
SCHEMBL3499593 0.91 FNTA (0.57) FNTAPGGT1BFNTBNRASHRAS
SCHEMBL3499750 0.88 FNTA (0.54) FNTAPGGT1BFNTBNRASHRAS
SCHEMBL3500642 0.86 FNTA (0.62) FNTAPGGT1BFNTBNRASHRAS
Hydrochloric Acid SCHEMBL8067266 0.85 FNTA (0.61) FNTAPGGT1BFNTBNRASHRAS
L-778123 Free Base SCHEMBL7194384 0.81 FNTA (1.00) FNTAPGGT1BFNTBNRASHRAS
L-778123 Free Base SCHEMBL1683541 0.81 FNTA (1.00) FNTAPGGT1BFNTBNRASHRAS
L-778123 Free Base SCHEMBL31237533 0.81 FNTA (1.00) FNTAPGGT1BFNTBNRASHRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1014984-A1 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE Merck & Co., Inc. (US) 2000-07-05 EP claimed
WO-1999009985-A1 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1999-03-04 WO claimed
US-6387903-B1 ANTICANCER AGENT; CARDIOVASCULAR DISORDERS; VIRICIDES MERCK & CO., INC. 2002-05-14 US disclosed
US-6103487-A DETECTING MODULATORS THAT SUPPRESS THE ACTIVITY OF A TRANSFERASES; ANTICARCINOGENIC AGENTS MERCK & CO., INC. (US) 2000-08-15 US disclosed
EP-1019530-A1 A METHOD OF TREATING CANCER Merck & Co., Inc. (US) 2000-07-19 EP disclosed
WO-2000016626-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 2000-03-30 WO disclosed
WO-1999010524-A1 A METHOD OF TREATING CANCER MERCK & CO., INC. (US) 1999-03-04 WO disclosed